Efficacy of radiotherapy in pain and spinal cord compression syndrome treatment from bone metastases in prostate cancer patients with low performance status and life expectancy

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2006年 / 5卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [31] Psychological status and pain outcome evaluation in patients with painful bone metastases from castration resistant prostate cancer treated with 223Radium.
    Frantellizzi, Viviana
    Longo, Flavia
    Schinzari, Giovanni
    Liberatore, Mauro
    Pacilio, Massimiliano
    Bianco, Vincenzo
    Follacchio, Giulia Anna
    De Vincentis, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] Eastern Cooperative Oncology Group Performance Score Is Associated With Survival After Radiotherapy of Bone Metastases from Prostate Cancer
    Haus, Rapha
    Janssen, Stefan
    Schild, Steven E.
    Rades, Dirk
    IN VIVO, 2020, 34 (02): : 679 - 682
  • [33] Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer
    Konski, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (05): : 1373 - 1378
  • [34] Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy
    Dirk Rades
    Barbara Segedin
    Steven E. Schild
    Darejan Lomidze
    Theo Veninga
    Jon Cacicedo
    Radiation Oncology, 17
  • [35] Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy
    Rades, Dirk
    Segedin, Barbara
    Schild, Steven E.
    Lomidze, Darejan
    Veninga, Theo
    Cacicedo, Jon
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [36] Stereotactic radiotherapy for patients with bone metastases: a selected group with low rate of radiation treatment during the last month of life?
    Nieder, Carsten
    Haukland, Ellinor C.
    Stanisavljevic, Luka
    Mannsaker, Bard
    RADIATION ONCOLOGY, 2024, 19 (01)
  • [37] Administration of zoledronic acid before the onset of bone pain may be more effective in patients with bone metastases from prostate cancer
    Saad, F.
    Gleason, D.
    Chen, Y. M.
    Eastham, J.
    CANCER TREATMENT REVIEWS, 2006, 32 : S33 - S33
  • [38] Efficacy of samarium 153 and strontium 89 treatment for bone metastases in prostate cancer patients: monotherapy vs. treatment combined with external beam radiotherapy. Preliminary report
    Baczyk, Maciej
    Milecki, Piotr
    Martenka, Piotr
    Sowinski, Jerzy
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2007, 12 (04) : 211 - 216
  • [39] Zoledronic acid reduces the survival-adjusted cumulative incidence of radiotherapy to bone in patients with bone metastases from breast or prostate cancer
    Major, Pierre P.
    Cook, Richar J.
    Chen, Bee-Lian
    Zheng, Ming
    ANNALS OF ONCOLOGY, 2004, 15 : 124 - 124
  • [40] Comprehensive genomic profiling unravels molecular targets in patients with metastatic spinal cord compression from prostate cancer.
    Duong, Tony
    Wang, Jue
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
12345